Vanguard Group (MXL) discloses 15.25% beneficial stake in MaxLinear
Rhea-AI Filing Summary
The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 13,326,387 shares of MaxLinear Inc common stock, representing 15.25% of the class as of December 31, 2025. Vanguard reports no sole voting or dispositive power, but shared voting power over 654,535 shares and shared dispositive power over all 13,326,387 shares.
Vanguard states the shares are held in the ordinary course of business and not to change or influence control of MaxLinear. The filing also notes an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries may report beneficial ownership separately while pursuing the same investment strategies as before.
Positive
- None.
Negative
- None.
Insights
Vanguard discloses a 15.25% passive stake in MaxLinear.
The Vanguard Group reports beneficial ownership of 13,326,387 MaxLinear shares, or
The filing characterizes this position as held in the ordinary course of business and explicitly states it is not for the purpose of changing or influencing control. This aligns with a typical passive institutional holder under a Schedule 13G, rather than an activist posture or control transaction.
The document also describes an internal realignment on